SCHEMBL10107525

SCHEMBL10107525

CCCCOc1cncc(Cl)c1C(=O)OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.51
PDE4B Q07343 1/20 0.51
PDE4C Q08493 1/20 0.51
PDE4D Q08499 1/20 0.51
TSHR P16473 4/20 0.39
L3MBTL1 Q9Y468 4/20 0.39
ALDH1A1 P00352 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 2/20 0.39
ESR1 P03372 1/20 0.38
TP53 P04637 2/20 0.38
GAA P10253 2/20 0.38
MRGPRX4 Q96LA9 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15374833 0.87 PDE4A (0.45) PDE4APDE4BPDE4CPDE4DTSHR
SCHEMBL6128444 0.85 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DTSHR
SCHEMBL10107524 0.84 NPC1 (0.42) PDE4APDE4BPDE4CPDE4DTSHR
SCHEMBL5031267 0.82 LMNA (0.48) PDE4APDE4BPDE4CPDE4DTSHR
SCHEMBL6257319 0.78 ITGB1 (0.40) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4135468 0.78 ATM (0.46) PDE4DTSHRALDH1A1NPSR1LMNA
SCHEMBL10101806 0.77 EGFR (0.51) PDE4DALDH1A1LMNAMRGPRX4HTT
SCHEMBL5333059 0.75 ESR1 (0.43) L3MBTL1ALDH1A1NPSR1LMNAESR1
SCHEMBL10107491 0.73 NPC1 (0.43) PDE4APDE4BPDE4CPDE4DTSHR
SCHEMBL16482815 0.72 THRB (0.50) PDE4APDE4BPDE4CPDE4DTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8828988-B2 8-AZA tetracycline compounds TETRAPHASE PHARMACEUTICALS, INC. (US) 2014-09-09 US disclosed
US-8367654-B2 8-AZA tetracycline compounds TETRAPHASE PHARMACEUTICALS, INC. (US) 2013-02-05 US disclosed
US-20120108569-A1 8-AZA Tetracycline Compounds TETRAPHASE PHARMACEUTICALS, INC. 2012-05-03 US disclosed
WO-2010129055-A1 8-AZA TETRACYCLINE COMPOUNDS TETRAPHASE PHARMACEUTICALS, INC. (US) 2010-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108569-A1 8-AZA Tetracycline Compounds TET1, TET3, HDAC8 PDE4A 338/4885PDE4B 399/4885PDE4C 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.